PTA Balloon Catheter Market Report 2026

PTA Balloon Catheter Market Overview

• PTA Balloon Catheter market size has reached to $2.56 billion in 2025 • Expected to grow to $4.31 billion in 2030 at a compound annual growth rate (CAGR) of 10.8% • Growth Driver: Increasing Prevalence Of Cardiovascular Disorders Driving Market Growth Due To Higher Demand For Minimally Invasive Vascular Interventions • Market Trend: Embedding Serration Technology To Enhance Vessel Preparation And Improve Dilatation Efficiency • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under PTA Balloon Catheter Market?

PTA balloon catheter is a medical procedure that is intended to enlarge a narrowed vessel opening using a small, flexible plastic tube, or catheter, with a balloon at the end of it. This is used during the minimally invasive catheterization procedure. The main types of PTA balloon catheters are polyurethane and nylon. Polyurethane is a material that is made from plastic that is in various forms. The various applications include coronary artery disease and peripheral vascular disease, that are used in hospitals, ambulatory surgical centers and others.

What Is The PTA Balloon Catheter Market Growth Forecast?

The pta balloon catheter market size is expected to see rapid growth in the next few years. It will grow to $4.31 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to increasing adoption of advanced endovascular therapies, rising focus on outpatient vascular procedures, expansion of peripheral artery disease treatment, growing investments in catheter innovation, increasing preference for minimally invasive solutions. Major trends in the forecast period include increasing adoption of drug-coated balloon technologies, rising use of minimally invasive vascular procedures, growing demand for high-precision balloon catheters, expansion of peripheral vascular interventions, enhanced focus on biocompatible catheter materials.

Global PTA Balloon Catheter Market Segmentation

1) By Type: Polyurethane, Nylon 2) By Application: Coronary Artery Disease, Peripheral Vascular Disease 3) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users Subsegments: 1) By Polyurethane: Non-compliant Balloons, Compliant Balloons 2) By Nylon: Non-compliant Balloons, Compliant Balloons

What Is The Driver Of The PTA Balloon Catheter Market?

The increasing prevalence of cardiovascular disorders is expected to propel the growth of the percutaneous transluminal angioplasty (PTA) balloon catheter market going forward. Cardiovascular disorders refer to conditions such as peripheral artery disease (PAD), atherosclerosis, and coronary artery disease, which involve narrowed or blocked blood vessels that restrict blood flow. This rise in cardiovascular cases is driven by aging populations, sedentary lifestyles, obesity, and risk factors such as hypertension and diabetes. The increasing prevalence of cardiovascular disorders supports the PTA balloon catheter market by boosting the need for minimally invasive procedures that restore vessel patency, improve circulation, and reduce the risk of severe complications. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, up 4.0% from 224.4 per 100,000 in 2023. Therefore, the increasing prevalence of cardiovascular disorders is driving the growth of the PTA balloon catheter industry.

Key Players In The Global PTA Balloon Catheter Market

Major companies operating in the pta balloon catheter market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Lepu Medical, B. Braun Corporation, Terumo, Nipro Medical, Teleflex, Cook Medical, Biotronik, Merit Medical, Microport Scientific, Cardiovascular Systems, Well Lead Medical, Cardionovum, JOTEC, Creagh Medical, Natec Medical, TriReme Medical, Andratec, Acotec Scientific, Kaneka Corporation

Global PTA Balloon Catheter Market Trends and Insights

Major companies operating in the percutaneous transluminal angioplasty (PTA) balloon catheter market are focusing on technological developments such as serration technology, to improve lesion crossing, enable controlled dilatation, and enhance procedural outcomes in complex peripheral artery disease cases. Serration technology refers to the incorporation of precision-engineered serrated elements along the balloon surface that create micro-incisions in the vessel during inflation, allowing for more predictable luminal gain with reduced trauma compared to conventional high-pressure balloons. For instance, in February 2025, Cagent Vascular, a US-based endovascular device manufacturer, launched its Serranator SL Pro, a next-generation serration-enhanced PTA balloon catheter developed for patients with chronic limb-threatening ischemia (CLTI) and pedal artery disease. The device uses the company’s proprietary Serration Technology to treat diffuse, calcified, and highly resistant lesions by producing controlled, longitudinal micro-serrations that facilitate effective vessel expansion at lower inflation pressures. The launch aims to provide improved vessel preparation in below-the-ankle interventions while reducing the risk of dissection and minimizing the need for adjunctive high-pressure therapies.

What Are Latest Mergers And Acquisitions In The PTA Balloon Catheter Market?

In November 2023, OrbusNeich Medical Group Holdings Limited, a Hong Kong-based medical device company specializing in percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) devices, acquired Eucatech AG, for EUR 2.4 million. With this acquisition, OrbusNeich aims to enrich its PTA balloon catheter market offering by integrating Eucatech’s CE-marked paclitaxel-coated PTA balloons, along with coronary drug-eluting balloons, self-expandable stents, and sirolimus-eluting coronary stents. Eucatech AG is a Germany-based medical engineering company focused on minimally invasive cardiovascular and endovascular products, including paclitaxel-coated coronary and peripheral (PTA) balloons.

Regional Outlook

North America was the largest region in the PTA balloon catheter market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the PTA Balloon Catheter Market?

The PTA balloon catheter market consists of sales of non-compliant (high-pressure) balloons, semi-compliant (mid pressure), and compliant (elastomeric) balloons. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.